ABVC BIOPHARMA, INC. annual report, FY2012

Business context and reporting period

This document is Ecology Coatings, Inc.’s Form 10-K for the fiscal year ended September 30, 2013, filed April 16, 2015. The request metadata names ABVC Biopharma and “2012 Q4,” which do not match the company or reporting period in the filing. The company described its business as coatings technology, but reported no employees and stated that its operating history no longer applied after its Chapter 7 bankruptcy.

Financial performance and condition

MetricFY 2013FY 2012
Revenue$7,787$5,714
Operating expenses$185,046$1,148,760
Operating loss$177,259$1,143,046
Net loss$226,352$1,069,579
Cash used in operating activities$37,768$915,124
Cash at year-end$618$13,386

At September 30, 2013, total assets were $231,969, current assets $1,856, current liabilities $2,112,143, and stockholders’ deficit $1,880,174. Current liabilities included $1,138,500 of related-party notes, $604,330 of judgment payable, and $189,845 of interest payable. The filing reports no interest paid in either year. No clear gross-margin or operating-margin figure is provided.

Changes versus prior year

Revenue increased by $2,073, while operating expenses fell by approximately $963,000, principally due to lower compensation and professional fees. Net loss narrowed by approximately $843,000. The 2012 results included $228,802 of debt-forgiveness income and $395,000 of preferred-stock beneficial conversion features charged in calculating loss attributable to common shareholders; FY 2013 reported no debt-forgiveness income.

Outlook, risks, and unusual items

  • The company filed for Chapter 7 bankruptcy on May 15, 2013. It said it emerged on September 19, 2014 with the corporate shell as its only unencumbered asset and liabilities settled; it described that date as the fresh-start date for subsequent filings.
  • The auditor’s report raises substantial doubt about the company’s ability to continue as a going concern. The filing also states that liabilities exceeded assets by approximately $1.9 million before the bankruptcy resolution.
  • Management identified risks including the need for capital, uncertain ability to launch a new business plan, and inability to commercialize technology or generate revenue and profitability. No specific operating guidance is provided.
  • Disclosure controls and internal control over financial reporting were reported ineffective, citing weak monitoring and lack of segregation of duties in a one-person finance function.
  • Federal net operating loss carryforwards were reported at approximately $5.76 million, fully offset by a valuation allowance; their future use may be limited.

Most important facts to verify

  • Confirm the intended issuer and period: this filing is for Ecology Coatings, Inc. and FY ended September 30, 2013, not ABVC Biopharma or 2012 Q4.
  • Review the bankruptcy settlement and fresh-start accounting; the reported operating results and liabilities predate the company’s emergence.
  • Check subsequent filings and current business, capital structure, liquidity, and ability to meet SEC reporting obligations.
  • Reconcile share-count disclosures: the filing contains differing share figures in its ownership discussion, while the balance sheet reports 54,593,032 common shares at September 30, 2013.